Veru Announces Full Enrollment For Phase 2B Plateau Clinical Trial Of Enobosarm And Semaglutide Combination For High Quality Weight Loss
VERU•Full enrollment announced for Phase 2B Plateau trial
July 27 (Reuters) - Veru Inc VERU.O:
- Veru announces full enrollment for Phase 2B Plateau clinical trial of enobosarm and semaglutide combination for high quality weight loss
- Veru - interim analysis results for Phase 2B Plateau trial expected in Q1 2027
- Veru - final topline data for Phase 2B Plateau trial expected in Q4 2027
